8 completed, 4 recruiting, 1 active not recruiting. 7 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Recruiting 3, Active not recruiting 1 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Meningococcal Vaccines: new trials by email Literature Review of Meningococcal Vaccines trials Research Report on Meningococcal Vaccines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months experimental vaccine, Active Comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Recruiting | Sinovac Biotech Co., Ltd | 880 | 2026-03-25 | 2026-08-10 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months experimental vaccine, Active Comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Recruiting | Sinovac Biotech Co., Ltd | 1040 | 2026-03-22 | 2026-08-10 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months experimental vaccine, Active Comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Recruiting | Sinovac Biotech Co., Ltd | 1040 | 2026-03-22 | 2026-08-10 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years experimental vaccine, active comparator vaccine - Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Active not recruiting | Sinovac Biotech Co., Ltd | 660 | 2026-03-22 | 2026-08-10 |
| A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States. Trumenba Vaccine, MenACWY Vaccine - Gonorrhea, Chlamydia | Completed | Pfizer | 1307378 | 2023-04-24 | 2025-04-17 | |
| Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults Adjuvanted MCV-5, Non-Adjuvanted MCV-5, Menactra® - Meningococcal Vaccines | Phase 1 | Completed | PATH | 60 | 2016-08-01 | 2021-06-09 |
| Investigating Meningococcal Vaccines in Adults 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics - Meningococcal Vaccines, Meningococcal Infections | Not applicable | Completed | University of Oxford | 15 | 2015-04-01 | 2021-10-27 |
| A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 rLP2086 and Gardasil, rLP2086, Gardasil - Vaccines, Meningococcal Vaccines | Phase 2 | Completed | Pfizer | 2499 | 2011-09-28 | 2018-12-19 |
| A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age rLP2086 + MCV4 + Tdap, MCV4 + Tdap + saline, rLP2086 + saline - Vaccines, Meningococcal Vaccines | Phase 2 | Completed | Pfizer | 2648 | 2011-09-28 | 2018-12-20 |
| Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children Nimenrix (GSK134612 vaccine), Menjugate - Infections, Meningococcal, Meningococcal Vaccines | Phase 3 | Completed | GlaxoSmithKline | 271 | 2011-01-03 | 2020-11-23 |
| Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines Nimenrix™, Menjugate®, NeisVac-CTM - Infections, Meningococcal, Meningococcal Vaccines | Phase 3 | Completed | GlaxoSmithKline | 2095 | 2010-07-01 | 2020-12-31 |
| Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects Nimenrix, Mencevax - Infections, Meningococcal, Meningococcal Vaccines | Phase 3 | Completed | GlaxoSmithKline | 1504 | 2007-09-18 | 2020-10-27 |
| National Bacterial Meningitis Study in Children and Newborns Meningitis, Children, Only | Recruiting | Association Clinique Thérapeutique Infantile du val de Marne | 10000 | 2001-01-01 | 2026-04-28 |
Meningitis, Meningococcal (4) · Meningococcal Infections (4) · Chlamydia Infections (1) · Gonorrhea (1) · Meningitis (1)
Bacterial Infections (9) · Bacterial Infections and Mycoses (9) · Gram-Negative Bacterial Infections (9) · Infections (9) · Neisseriaceae Infections (9) · Nervous System Diseases (5) · Neuroinflammatory Diseases (5) · Central Nervous System Bacterial Infections (4) · Central Nervous System Diseases (4) · Central Nervous System Infections (4) · Meningitis (4) · Meningitis, Bacterial (4) · Meningococcal Infections (4) · Chlamydiaceae Infections (1) · Communicable Diseases (1)
4CMenB vaccine (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · MenB-FHbp vaccine (1) · Meningococcal Vaccines (1) · PHiD-CV vaccine (1) · Sodium Chloride (1) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (1) · factor H-binding protein, Neisseria meningitidis (1)
Sinovac Biotech Co., Ltd (4) · GlaxoSmithKline (3) · Pfizer (3) · Association Clinique Thérapeutique Infantile du val de Marne (1) · PATH (1) · University of Oxford (1)
China (4) · United States (4) · France (2) · Germany (2) · Estonia (1) · India (1) · Lebanon (1) · Philippines (1) · Saudi Arabia (1) · Spain (1) · United Kingdom (1)
Corinne Levy, MD (1) · Robert Cohen (1) · Wilbur Chen, MD,MS (1)
PMID 32681472, PMID 35164991, PMID 27847367, PMID 30120069, PMID 38108805, PMID 40063777, PMID 40924727, PMID 41276263
2009 (1)